Bacterin
International, BONE, Profile, Summary
Bacterin
International Holdings (NYSE:
BONE), a developer of
bioactive coatings for medical applications and revolutionary bone
graft material, processes and markets innovative, biologic allografts
for transplantation. The Company’s biologic scaffolds,
OsteoSponge®,
OsteoSponge®
SC and OsteoWrap®,
are made from demineralized bone that is malleable and flexible,
which enables more efficient and precise handling. It also markets
BacFast®
and OsteoLock®,
which are used in spine surgery, designed to minimize graft back-out,
and increase osteoinductivity. Bacterin's latest allograft,
OsteoSelect®
DBM Putty has excellent handling characteristics and is distributed
as a sterile product, with osteoinductivity testing completed on
every lot after terminal sterilization.
Bacterin’s
Medical Device and Coatings Division focuses on the development of
bioactive coating technologies for implantable devices. It’s core
competency is anti-microbial coatings designed to reduce potential
infections associated with implants, thus improving rates of
healthcare-associated infections and associated costs. This Division
also manages surgical kits necessary to support implantation of
products processed by Bacterin’s Biologics Division.
Bacterin
is an accredited tissue bank and medical device company that designs,
processes, manufactures, and markets advanced medical products. Using
designs focused on efficacy and safety for the patient, and
functionality and ease of use for the surgeon. Bacterin is a
specialty tissue bank focused on processing and distributing quality,
cost-effective allografts. Bacterin operates a 32,000 sq. ft.,
state-of-the-art, fully compliant and FDA registered facility,
equipped with five "Class 100" clean room
Bone,
skin, sking grafts, plastic surgery, osteo sponge, biologics, bone
grafts, osteeporosis. Menopause, post menopause, Bacterin, natural
medical devices.
Daily Stock Deals
